The device was returned for analysis.The reported stent dislodgement was confirmed.The reported difficulty to remove the sheath could not be confirmed due to the condition the device was returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.It was reported that during preparation of the 3.5x33mm xience pros stent delivery system (sds) it was not possible to remove the yellow cover from the device.Extra force was used; however, was unsuccessful.It should be noted that the xience sierra (pro s) everolimus eluting coronary stent system instruction for use states: remove the product mandrel and protective stent sheath by grasping the catheter just proximal to the stent, and with the other hand, grasp the stent protector and gently remove distally.If unusual resistance is felt during product mandrel and stent sheath removal, do not use this product and replace with another.In this case, it does not appear that the instruction for use (ifu) deviation related to excessive force during sheath removal caused the reported event.The investigation was unable to determine a conclusive cause for the reported difficulty to remove the sheath.The reported stent dislodgment appears to be related to operational context of the procedure as it is likely handling and/or the excessive force used during the difficult removal of the sheath caused the reported stent dislodgment.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|